While producing physicians who will shape the future of health care, the school’s mission is to improve medicine through cutting-edge research, excellence in patient care, and innovations in medical education. The SOM has an accomplished faculty that includes four Nobel Prize winners, two of whom received the award in 2006. Of 750 faculty members, 30 have been elected to the National Academy of Sciences, 41 are members of the Institute of Medicine, and 13 serve as investigators for the Howard Hughes Medical Institute. The school is consistently ranked among the top 10 medical schools in the USA.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Drug discovery solutions are provided in form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates and consulting arrangements. The Company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, immunooncology and infectious diseases. By leveraging this expertise, Evotec intends to develop best-inclass and first-in-class differentiated therapeutics on its systematic, unbiased and comprehensive infrastructure.